K26: Individualized therapy for incurable breast cancer patients and elucidation of resistance mechanisms

HIPO Investigator:

Prof. Dr. Schneeweiss

Dr. Marc Zapatka


Supported by: HIPO

Entity: Breast Cancer

DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.